Literature DB >> 22954224

Implications of genetic heterogeneity in cancer.

Michael W Schmitt1, Marc J Prindle, Lawrence A Loeb.   

Abstract

DNA sequencing studies have established that many cancers contain tens of thousands of clonal mutations throughout their genomes, which is difficult to reconcile with the very low rate of mutation in normal human cells. This observation provides strong evidence for the mutator phenotype hypothesis, which proposes that a genome-wide elevation in the spontaneous mutation rate is an early step in carcinogenesis. An elevated mutation rate implies that cancers undergo continuous evolution, generating multiple subpopulations of cells that differ from one another in DNA sequence. The extensive heterogeneity in DNA sequence and continual tumor evolution that would occur in the context of a mutator phenotype have important implications for cancer diagnosis and therapy.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2012        PMID: 22954224      PMCID: PMC3674777          DOI: 10.1111/j.1749-6632.2012.06590.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  35 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Evolving responsively: adaptive mutation.

Authors:  S M Rosenberg
Journal:  Nat Rev Genet       Date:  2001-07       Impact factor: 53.242

3.  Protein tolerance to random amino acid change.

Authors:  Haiwei H Guo; Juno Choe; Lawrence A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

4.  Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype.

Authors:  Marta B Davidson; Yuki Katou; Andrea Keszthelyi; Tina L Sing; Tian Xia; Jiongwen Ou; Jessica A Vaisica; Neroshan Thevakumaran; Lisette Marjavaara; Chad L Myers; Andrei Chabes; Katsuhiko Shirahige; Grant W Brown
Journal:  EMBO J       Date:  2012-01-10       Impact factor: 11.598

5.  Down-regulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers.

Authors:  Qiangrong Pan; Yongming Fang; Yang Xu; Kun Zhang; Xun Hu
Journal:  Cancer Lett       Date:  2005-01-20       Impact factor: 8.679

6.  Fidelity of HIV-1 reverse transcriptase.

Authors:  B D Preston; B J Poiesz; L A Loeb
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

Review 7.  Errors in DNA replication as a basis of malignant changes.

Authors:  L A Loeb; C F Springgate; N Battula
Journal:  Cancer Res       Date:  1974-09       Impact factor: 12.701

8.  Fitness of an Escherichia coli mutator gene.

Authors:  T C Gibson; M L Scheppe; E C Cox
Journal:  Science       Date:  1970-08-14       Impact factor: 47.728

9.  Lethal mutagenesis of HIV with mutagenic nucleoside analogs.

Authors:  L A Loeb; J M Essigmann; F Kazazi; J Zhang; K D Rose; J I Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.

Authors:  Catherine Roche-Lestienne; Valerie Soenen-Cornu; Nathalie Grardel-Duflos; Jean-Luc Laï; Nathalie Philippe; Thierry Facon; Pierre Fenaux; Claude Preudhomme
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

View more
  25 in total

Review 1.  The influence of subclonal resistance mutations on targeted cancer therapy.

Authors:  Michael W Schmitt; Lawrence A Loeb; Jesse J Salk
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

2.  Novel diet-related mouse model of colon cancer parallels human colon cancer.

Authors:  Anil R Prasad; Shilpa Prasad; Huy Nguyen; Alexander Facista; Cristy Lewis; Beryl Zaitlin; Harris Bernstein; Carol Bernstein
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

3.  Sequencing small genomic targets with high efficiency and extreme accuracy.

Authors:  Michael W Schmitt; Edward J Fox; Marc J Prindle; Kate S Reid-Bayliss; Lawrence D True; Jerald P Radich; Lawrence A Loeb
Journal:  Nat Methods       Date:  2015-04-06       Impact factor: 28.547

Review 4.  Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature.

Authors:  Bita Fakhri; Kian-Huat Lim
Journal:  J Gastrointest Oncol       Date:  2017-06

Review 5.  Challenges and opportunities in childhood cancer drug development.

Authors:  Robin E Norris; Peter C Adamson
Journal:  Nat Rev Cancer       Date:  2012-10-11       Impact factor: 60.716

6.  Detecting ultralow-frequency mutations by Duplex Sequencing.

Authors:  Scott R Kennedy; Michael W Schmitt; Edward J Fox; Brendan F Kohrn; Jesse J Salk; Eun Hyun Ahn; Marc J Prindle; Kawai J Kuong; Jiang-Cheng Shen; Rosa-Ana Risques; Lawrence A Loeb
Journal:  Nat Protoc       Date:  2014-10-09       Impact factor: 13.491

Review 7.  T lymphocytes targeting native receptors.

Authors:  Cliona M Rooney; Ann M Leen; Juan F Vera; Helen E Heslop
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data.

Authors:  Wenyuan Li; Qingjiao Li; Shuli Kang; Mary Same; Yonggang Zhou; Carol Sun; Chun-Chi Liu; Lea Matsuoka; Linda Sher; Wing Hung Wong; Frank Alber; Xianghong Jasmine Zhou
Journal:  Nucleic Acids Res       Date:  2018-09-06       Impact factor: 16.971

9.  Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance.

Authors:  Matilda Rentoft; Kristoffer Lindell; Phong Tran; Anna Lena Chabes; Robert J Buckland; Danielle L Watt; Lisette Marjavaara; Anna Karin Nilsson; Beatrice Melin; Johan Trygg; Erik Johansson; Andrei Chabes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

10.  A new kink in an old theory of carcinogenesis.

Authors:  Richmond T Prehn; Liisa M Prehn
Journal:  Theor Biol Med Model       Date:  2013-02-18       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.